Open Access

Annexin A3 and cancer (Review)

  • Authors:
    • Chao Liu
    • Nannan Li
    • Guijian Liu
    • Xue Feng
  • View Affiliations

  • Published online on: October 14, 2021
  • Article Number: 834
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Annexin A3 (ANXA3), an annexin family member, contains 36 kDa and 33 kDa isoforms. Similar to other annexin members, ANXA3 plays an important role in the development of human diseases. Recent studies have reported that abnormal ANXA3 expression is closely associated with the development, progression, metastasis, drug resistance and prognosis of several malignant tumours, such as breast cancer, lung cancer and hepatocellular carcinoma. ANXA3 exerts its role by regulating cell proliferation, migration and apoptosis via the phosphatidylinositol‑3 kinase/Akt, nuclear factor‑κB (NF‑κB), c‑JUN N‑terminal kinase, extracellular signal‑regulated kinase and hypoxia‑inducible factor‑1 signalling pathways. ANXA3 may act as a novel target for the early diagnosis and treatment of tumours. The present review summarises the recent progress in the role of ANXA3 and its regulatory pathways in tumours.

Related Articles

Journal Cover

Volume 22 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
Spandidos Publications style
Liu C, Li N, Liu G and Feng X: Annexin A3 and cancer (Review). Oncol Lett 22: 834, 2021
Liu, C., Li, N., Liu, G., & Feng, X. (2021). Annexin A3 and cancer (Review). Oncology Letters, 22, 834.
Liu, C., Li, N., Liu, G., Feng, X."Annexin A3 and cancer (Review)". Oncology Letters 22.6 (2021): 834.
Liu, C., Li, N., Liu, G., Feng, X."Annexin A3 and cancer (Review)". Oncology Letters 22, no. 6 (2021): 834.